PATENT CLAIM ANALYSIS

Application Number: 16042031
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "718000"]

Abstract:
The present invention provides methods of administering nitric oxide (NO) to a patient, the method comprising delivering nitric oxide-containing gas directly into arterial or arterialized blood. The methods of the present invention may be used in the treatment or prevention of a variety of diseases and disorders responsive to nitric oxide, including those resulting from ischemia or hypoxia.

Claim (Index 14):
An extracorporeal membrane oxygenation (ECMO) system comprising:\n a chamber, wherein blood enters an oxygenation compartment though an inlet in the chamber; an oxygen transfer unit having an oxygen permeable membrane, wherein the oxygen transfer unit is within the oxygenation compartment; and a nitric oxide (NO) transfer unit having an NO permeable membrane, wherein the oxygen transfer unit is separated from an upstream portion of the chamber by the oxygen permeable membrane which exchanges oxygen for carbon dioxide in the blood to produce arterialized blood, and the NO transfer unit is separated from a downstream portion of the chamber by the NO permeable membrane which exchanges NO for oxygen in the arterialized blood.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.3913
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14402786', '14095621', '10953747', '10384301', '13116219']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6875257935955459
- 35 USC 102 Novelty (BERT): 0.5815053772657841
- Combined Prediction Score: 0.6769237519625697
- Mean Citation Score: 283.736874
- Max Citation Score: 462.03397
- Similarity Product: 436.7430788005672

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test